Back | Next |
home / stock / vktx / vktx message board
Subject | By | Source | When |
---|---|---|---|
You can have a double blinded trial but | roadkilll | investorshub | 03/03/2023 4:06:35 PM |
znewcar1: $VKTX hod11.4 does it push to MH 11.8? | znewcar1 | investorshangout | 02/21/2023 3:18:51 PM |
Phase II data coming in second quarter | roadkilll | investorshub | 02/20/2023 4:53:28 PM |
`10.10 everybody win$ | TheFinalCD | investorshub | 02/08/2023 5:18:05 PM |
$9.99 this am. | roadkilll | investorshub | 02/08/2023 1:51:13 PM |
Come on, $VKTX !! | budgetthis | investorshub | 01/23/2023 11:12:43 PM |
Added a few today New 52 week highs | TechandBio | investorshub | 01/12/2023 10:48:13 PM |
$VKTX looks like 9's coming | TheFinalCD | investorshub | 01/06/2023 6:14:50 PM |
Added this am 8.23-8.25 | TechandBio | investorshub | 01/04/2023 2:38:24 PM |
Added some today at 8.05-8.10 | TechandBio | investorshub | 01/03/2023 8:54:27 PM |
I'm going to keep my entire position and | TechandBio | investorshub | 12/31/2022 7:18:00 PM |
No one loved it under $3.00 | TechandBio | investorshub | 12/30/2022 1:37:00 AM |
Selling half my shares at $12.50 then let | TechandBio | investorshub | 12/26/2022 11:43:47 PM |
what are you valuing the IP at? | L0tsaluck2000 | investorshub | 12/21/2022 1:56:03 PM |
$VKTX Book Value only $1.97 has $1.64M DEBT | BottomBounce | investorshub | 12/20/2022 1:06:04 AM |
znewcar1: $VKTX 73% v96,3M C6.99 f76,688M H7.25 PMH8.24 IDS8.8 | znewcar1 | investorshangout | 12/19/2022 10:56:31 PM |
The Analyst | roadkilll | investorshub | 12/19/2022 6:37:32 PM |
100 percent true. the medical industry | tootalljones | investorshub | 11/16/2022 11:32:52 PM |
Historic short interest: | XenaLives | investorshub | 05/27/2022 5:26:53 PM |
Historic short interest: | XenaLives | investorshub | 04/14/2022 4:52:36 PM |
News, Short Squeeze, Breakout and More Instantly...
Viking Therapeutics Inc. Company Name:
VKTX Stock Symbol:
NASDAQ Market:
Viking Therapeutics Inc. Website:
The obesity market has garnered much interest lately, ever since Novo Nordisk (NYSE: NVO) received FDA approval for its obesity drug Wegovy in 2021...
2024-05-16 15:15:03 ET Raymond James analyst issues STRONG BUY recommendation for VKTX on May 16, 2024 01:43PM ET. VKTX was trading at $69.81 at issue of the analyst recommendation. The overall analyst consensus : BUY. Current analyst recommendations are : 4 - Buy recomm...
2024-05-16 15:00:04 ET Joon Lee from Truist Financial issued a price target of $120.00 for VKTX on 2024-05-16 13:44:00. The adjusted price target was set to $120.00. At the time of the announcement, VKTX was trading at $69.525. The overall price target consensus is at $7...